Rani Therapeutics Announces Research Agreement with Chugai
May 19, 2025
Eiger BioPharmaceuticals to Host Conference Call for Third Quarter 2021 Financial Results and Business Update on Thursday, November 4
October 21, 2021
Related Post
-
-
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS
May 19, 2025
-
Ocugen Provides Business Update with First Quarter 2025 Financial Results
May 9, 2025
-
Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital
May 7, 2025